Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis

[1]  C. Coarfa,et al.  Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD , 2017, Scientific Reports.

[2]  A. L. Mindikoglu,et al.  New Developments in Hepatorenal Syndrome , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  J. Bonventre,et al.  Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease , 2017, Diabetes Care.

[4]  C. Coarfa,et al.  Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis. , 2016, Cancer cell.

[5]  E. Cholongitas,et al.  Comparison of creatinine and cystatin formulae with 51Chromium‐ethylenediaminetetraacetic acid glomerular filtration rate in patients with decompensated cirrhosis , 2016, Journal of Gastroenterology and Hepatology.

[6]  Christian Gieger,et al.  A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population. , 2016, Journal of the American Society of Nephrology : JASN.

[7]  L. Magder,et al.  Estimation of Glomerular Filtration Rate in Patients With Cirrhosis by Using New and Conventional Filtration Markers and Dimethylarginines. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  J. Friedewald,et al.  Urine Metabolite Profiles Predictive of Human Kidney Allograft Status. , 2016, Journal of the American Society of Nephrology : JASN.

[9]  K. Veselkov,et al.  Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis , 2016, Journal of hepatology.

[10]  Minoru Kanehisa,et al.  KEGG as a reference resource for gene and protein annotation , 2015, Nucleic Acids Res..

[11]  Coral Barbas,et al.  Missing value imputation strategies for metabolomics data , 2015, Electrophoresis.

[12]  N. Ferreirós,et al.  Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis , 2015, PloS one.

[13]  Neil A. Miller,et al.  Renal systems biology of patients with systemic inflammatory response syndrome , 2015, Kidney international.

[14]  J. Zhao,et al.  Serum sphingomyelin has potential to reflect hepatic injury in chronic hepatitis B virus infection. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[15]  Corey D. DeHaven,et al.  High Resolution Mass Spectrometry Improves Data Quantity and Quality as Compared to Unit Mass Resolution Mass Spectrometry in High- Throughput Profiling Metabolomics , 2014 .

[16]  John P A Ioannidis,et al.  Design and analysis of metabolomics studies in epidemiologic research: a primer on -omic technologies. , 2014, American journal of epidemiology.

[17]  L. Magder,et al.  A Pilot Study to Evaluate Renal Hemodynamics in Cirrhosis by Simultaneous Glomerular Filtration Rate, Renal Plasma Flow, Renal Resistive Indices and Biomarkers Measurements , 2014, American Journal of Nephrology.

[18]  L. Magder,et al.  Performance of chronic kidney disease epidemiology collaboration creatinine‐cystatin C equation for estimating kidney function in cirrhosis , 2014, Hepatology.

[19]  R. Moreau,et al.  Glomerular filtration rate equations for liver‐kidney transplantation in patients with cirrhosis: Validation of current recommendations , 2014, Hepatology.

[20]  T. Meyer,et al.  Uremic solutes and risk of end stage renal disease in type 2 diabetes , 2014, Kidney international.

[21]  C. Soulage,et al.  Potential role and therapeutic interests of myo-inositol in metabolic diseases. , 2013, Biochimie.

[22]  J. Slotte,et al.  Biological functions of sphingomyelins. , 2013, Progress in lipid research.

[23]  O. Sergeeva.  GABAergic transmission in hepatic encephalopathy. , 2013, Archives of biochemistry and biophysics.

[24]  David S. Wishart,et al.  HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..

[25]  Shelly C. Lu,et al.  S-adenosylmethionine in liver health, injury, and cancer. , 2012, Physiological reviews.

[26]  Harold I Feldman,et al.  Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.

[27]  Corey Donald DeHaven,et al.  Software Techniques for Enabling High-Throughput Analysis of Metabolomic Datasets , 2012 .

[28]  K. Mullen,et al.  Theories of the pathogenesis of hepatic encephalopathy. , 2012, Clinics in liver disease.

[29]  Steven A. Brown,et al.  The human circadian metabolome , 2012, Proceedings of the National Academy of Sciences.

[30]  Helga Thorvaldsdóttir,et al.  Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..

[31]  Gaël Varoquaux,et al.  The NumPy Array: A Structure for Efficient Numerical Computation , 2011, Computing in Science & Engineering.

[32]  Anne M. Evans,et al.  Organization of GC/MS and LC/MS metabolomics data into chemical libraries , 2010, J. Cheminformatics.

[33]  K. Tiedje,et al.  β-Alanine as a small molecule neurotransmitter , 2010, Neurochemistry International.

[34]  R. Moreau,et al.  Inaccuracies of creatinine and creatinine‐based equations in candidates for liver transplantation with low creatinine: Impact on the model for end‐stage liver disease score , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[35]  David S. Wishart,et al.  HMDB: a knowledgebase for the human metabolome , 2008, Nucleic Acids Res..

[36]  T. Therneau,et al.  Hyponatremia and mortality among patients on the liver-transplant waiting list. , 2008, The New England journal of medicine.

[37]  Yusuf A. Hannun,et al.  Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.

[38]  E. Cholongitas,et al.  Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality , 2007, European journal of gastroenterology & hepatology.

[39]  John D. Hunter,et al.  Matplotlib: A 2D Graphics Environment , 2007, Computing in Science & Engineering.

[40]  Travis E. Oliphant,et al.  Python for Scientific Computing , 2007, Computing in Science & Engineering.

[41]  Ying Zhang,et al.  HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..

[42]  H. Omran,et al.  Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism. , 2006, American journal of human genetics.

[43]  Shelly C. Lu,et al.  Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer. , 2005, Alcohol.

[44]  A. V. van Kuilenburg,et al.  beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities. , 2004, Human molecular genetics.

[45]  C. McClain,et al.  S‐adenosylhomocysteine sensitizes to TNF‐α hepatotoxicity in mice and liver cells: A possible etiological factor in alcoholic liver disease , 2004, Hepatology.

[46]  I. Marshall,et al.  Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[47]  S. Craig,et al.  Betaine in human nutrition. , 2004, The American journal of clinical nutrition.

[48]  M. Uysal,et al.  Betaine or taurine administration prevents fibrosis and lipid peroxidation induced by rat liver by ethanol plus carbon tetrachloride intoxication , 2004, Amino Acids.

[49]  K. Kharbanda,et al.  Betaine lowers elevated s-adenosylhomocysteine levels in hepatocytes from ethanol-fed rats. , 2003, The Journal of nutrition.

[50]  M. Solioz,et al.  Betaine homocysteine methyltransferase: gene cloning and expression analysis in rat liver cirrhosis. , 2003, Biochimica et biophysica acta.

[51]  P. Thuluvath,et al.  Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation , 2002, Hepatology.

[52]  M. Kajiwara,et al.  Evaluation of 13C-phenylalanine and 13C-tyrosine breath tests for the measurement of hepatocyte functional capacity in patients with liver cirrhosis. , 2001, Chemical & pharmaceutical bulletin.

[53]  Shelly C. Lu,et al.  Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Shelly C. Lu,et al.  Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. , 2000, Journal of hepatology.

[55]  P. Kamath,et al.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.

[56]  D Botstein,et al.  Of Genes and Genomes , 1999, Annals of the New York Academy of Sciences.

[57]  J. Magdalou,et al.  Glucuronidation of drugs by hepatic microsomes derived from healthy and cirrhotic human livers. , 1999, The Journal of pharmacology and experimental therapeutics.

[58]  C Boesch,et al.  Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. , 1999, The Journal of clinical investigation.

[59]  D. Tuma,et al.  Dietary betaine promotes generation of hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration. , 1993, Alcoholism, clinical and experimental research.

[60]  M. Clifford,et al.  Colorimetric enumeration of Escherichia coli based on beta-glucuronidase activity , 1990, Applied and environmental microbiology.

[61]  J. Finkelstein,et al.  Methionine metabolism in mammals. , 1990, The Journal of nutritional biochemistry.

[62]  S. Sherlock,et al.  Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. , 1978, Gut.

[63]  E. Pitkänen.  Changes in serum and urinary myo-inositol levels in chronic glomerulonephritis. , 1976, Clinica chimica acta; international journal of clinical chemistry.

[64]  M. Orłowski,et al.  Intermediates of the γ-Glutamyl Cycle in Mouse Tissues , 1975 .

[65]  E. Rhee,et al.  An overview of renal metabolomics. , 2017, Kidney international.

[66]  P. Gillery,et al.  Post-translational modification derived products (PTMDPs): toxins in chronic diseases? , 2014, Clinical chemistry and laboratory medicine.

[67]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[68]  Kyoungmi Kim,et al.  Metabolomics in the study of kidney diseases , 2012, Nature Reviews Nephrology.

[69]  S. Cummings,et al.  Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study. , 2008, American heart journal.

[70]  Eric Jones,et al.  SciPy: Open Source Scientific Tools for Python , 2001 .

[71]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[72]  V. Spustová,et al.  Pseudouridine excretion in healthy subjects and its accumulation in renal failure. , 1992, Nephron.

[73]  M. Orłowski,et al.  Intermediates of the gamma-glutamyl cycle in mouse tissues. Influence of administration of amino acids on pyrrolidone carboxylate and gamma-glutamyl amino acids. , 1975, European journal of biochemistry.